Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma

Bristol-Myers Squibb · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
multiple-myeloma
multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 871733
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.